SCHEMBL24754397

SCHEMBL24754397

CN(C)C(=O)c1ccc(CN2Cc3ccccc3C2=O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.67
KMT2A Q03164 1/20 0.67
HDAC1 Q13547 5/20 0.58
HDAC7 Q8WUI4 2/20 0.50
KDM4E B2RXH2 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
SIRT1 Q96EB6 1/20 0.49
PARP1 P09874 1/20 0.43
HDAC4 P56524 3/20 0.43
HTR1A P08908 2/20 0.43
KCNH2 Q12809 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC2 Q92769 1/20 0.43
ACHE P22303 1/20 0.43
HDAC6 Q9UBN7 2/20 0.42
HTR2A P28223 1/20 0.41
TMEM97 Q5BJF2 1/20 0.41
BDKRB1 P46663 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1065002 0.84 MEN1 (0.69) MEN1KMT2AHDAC1HDAC7KDM4E
SCHEMBL2019296 0.83 MEN1 (0.67) MEN1KMT2AHDAC1HDAC7KDM4E
SCHEMBL30414177 0.80 MEN1 (0.48) MEN1KMT2AHDAC1HDAC7KCNH2
SCHEMBL25204255 0.80 MEN1 (0.48) MEN1KMT2AHDAC1HDAC7KCNH2
SCHEMBL31667008 0.79 KMT2A (0.62) MEN1KMT2AHDAC1HDAC7KDM4E
SCHEMBL2024836 0.79 KMT2A (0.66) MEN1KMT2AHDAC1HDAC7KDM4E
SCHEMBL27991792 0.79 KMT2A (0.62) MEN1KMT2AHDAC1HDAC7KDM4E
SCHEMBL1466305 0.79 KMT2A (0.60) MEN1KMT2AHDAC1HDAC7KDM4E
SCHEMBL29630944 0.79 KMT2A (0.60) MEN1KMT2AHDAC1HDAC7KDM4E
SCHEMBL3707181 0.79 MEN1 (0.62) MEN1KMT2AHDAC1HDAC7KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022263829-A1 COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY Z Factor Limited (GB) 2022-12-22 WO disclosed